Market Overview

UPDATE: JP Morgan Downgrades Itron to Neutral on Risk/Reward, Guidance

Related ITRI
Markets Marginally Lower In Quiet Trading Session
U.S. Stocks Rise; Nu Skin Shares Tumble On Downbeat Results

JP Morgan downgraded Itron (NASDAQ: ITRI) from Overweight to Neutral and lowered the price target from $47.00 to $45.50.

JP Morgan noted, "Initial revenue guidance for 2013 captures consensus expectations but is back-end loaded and visibility is impaired by the conclusion of major U.S. Openway AMI projects. 2013 EPS guidance is disappointing owing to elevated R&D and S&M expense originating in the need to invest ahead of International AMI program awards; for which the new CEO made a convincing case. We are trimming estimates to align with guidance, and lowering our Price Target accordingly. We remain constructive regarding the meter industry's long-term prospects, and Itron's strong position in international markets, but ITRI stock is trading close to our revised PT of $45.50."

Itron closed at $47.85 on Wednesday.

Posted-In: JP MorganAnalyst Color Downgrades Analyst Ratings

 

Related Articles (ITRI)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters